About a year ago, patients began marching into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify “might be right for them.”
Few appeared to be delusional, plagued by hallucinations or suffering fearsome mood swings. Mostly, they were depressed or anxious, and frustrated by the pace of their...
Read the rest of this article...